Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma

Update Il y a 5 ans
Reference: EUCTR2005-002827-15

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare overall survival for patients with advanced melanoma who are randomized toreceive ticilimumab with that of patients who are randomized to receive eitherdacarbazine or temozolomide.


Inclusion criteria

  • Advanced Melanoma